CAL-104

N/A

Report date: 2024/03/26 16:19:38

Base Information

Drug NameCAL-104

Drug Alias NameCAL-104CAL104

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionProtein S100-A4 modulatorsOxidized Phosphatidylcholine inhibitors

TargetsProtein S100-A4Oxidized Phosphatidylcholine

Therapy Area/IndicationsInflammationFibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNorway

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCalluna Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsInflammationFibrosis

Inactive IndicationsN/A

ATC CodeN/A